
Ozempic (GLP-1) Lawsuit — Free Case Review
Your Stomach Symptoms Were Real
If you took brand-name Ozempic, Wegovy, or Rybelsus and were diagnosed with a tested, documented stomach injury with an ER or hospital visit, you may qualify.
No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.
Did this happen to you — or someone you love?
Answered 24/7 · Free & confidential · No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney's fee is a percentage of the gross recovery, calculated before expenses are deducted.
Partners
Matthew T. Marin & Stefanie A. Murphy
Super Lawyers® honorees · American Association for Justice members
Ozempic inquiries get a personal review — and an honest answer either way, free and without obligation.
No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone's injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state. Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber. Attorney Advertising.
Vomiting that will not stop — often of food eaten many hours earlier — is the symptom that sends most people with GLP-1 stomach injuries to an emergency room, usually for dehydration, uncontrolled nausea, or an inability to keep anything down. Those ER and hospital records matter more than most people realize: the referral criteria for stomach-injury claims require an emergency room visit or hospital admission connected to the injury. Federal GLP-1 stomach cases are consolidated as MDL 3094, where 4,025 cases were pending as of October 2026.
Reports submitted to FDA are not verified and do not establish causation.
Free, confidential case review. Marin & Murphy is currently accepting Ozempic (GLP-1) gastroparesis and stomach-injury cases. No fee unless there is a recovery. Court costs and litigation expenses are advanced by counsel and repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted. Marin & Murphy is licensed in Rhode Island, Connecticut, Massachusetts, and South Carolina; matters elsewhere may be referred to lawyers licensed in your state.
Start your free case review or call (888) 348-2735 — answered 24/7. If your records don’t fit the current criteria, we will tell you.
See if you qualify
A few quick questions about which GLP-1 medication you took, your diagnosis and testing, and your treatment. This is the initial intake screening, not a full case review. Most people finish in about two minutes.
- 🔒 Confidential
- No obligation
- ⏱ ~2 minutes
Marin & Murphy Law Firm · Free & confidential · Stop messages anytime
What this actually looks like
It is rarely one dramatic episode. It is a pattern that grinds down over months: throwing up something you ate the night before, a body that just rejects solids, never knowing what will set it off. People stop eating in front of others. They keep a bag in the car.
Then something tips it over — a day of not keeping water down, a fainting spell, pain that gets frightening — and there is an ER visit. Then another. IV fluids, anti-nausea medication, bloodwork, sometimes an admission, often a discharge without a clear answer.
The downstream damage is worth naming, because people are frequently embarrassed by it: rapid weight loss and muscle wasting, weakness, teeth damaged by stomach acid, recurring dehydration, and the sheer cost — in money, in missed work, in time with family that got given up.
“They kept telling me nothing was wrong”
Being disbelieved is close to the standard experience here. People are told it is anxiety. They are told it is an eating disorder, sometimes for years, sometimes by specialists. They are told the medication cannot possibly still be doing this. Some are told, more or less, that people could see them eating so nothing could be wrong.
You are not the first person to be told this was in your head. Nothing on this page is a test of whether you are believable, and no part of a case review is designed to catch you out. The questions asked at intake are about dates and documents, not about whether the illness was real.
The drug worked. That’s what makes this hard.
Many people reading this got the result they were hoping for before the vomiting started, and some are still taking the medication now. Both things can be true. You can be grateful it worked and still be owed the truth about what it did.
Whatever your reason for taking it — that isn’t what this is about. What matters is what you were told about the risks, and what you weren’t. You did what your doctor and the label told you was safe.
Why the ER visit matters — and what it is not
The referral criteria for this track include a requirement that there was an emergency room visit or hospital admission connected to the stomach injury. It is worth being straightforward about why, because the requirement can land badly if it goes unexplained.
It is not a judgment that people who managed at home were less ill. Plenty of people were sicker at home for longer than someone else was in a hospital bed for two days. What an ER or admission record does is create contemporaneous, objective documentation — written by clinicians, at the time, for treatment reasons and not for a lawsuit. That is what a case is built from, and its absence is a proof problem rather than a credibility problem.
Practically: if you went in even once, even if they sent you home that night, it counts and is worth telling us about. Urgent care, infusion visits and repeat outpatient appointments are worth mentioning too, because what is in the chart is not always what you would expect.
If you never went in at all — you toughed it out, or had no insurance, or had been dismissed so often that going back felt pointless — say so anyway. That is a review path, not a closed door. It does not fit this referral track’s current criteria, and we will tell you so honestly, but criteria differ between firms and change over time.
The testing question, in one paragraph
If your diagnosis was gastroparesis, there is a second documentation issue you should know about: on August 15, 2025, the court overseeing these cases ruled that a gastroparesis claim must be supported by a properly performed gastric emptying study. Most people diagnosed with gastroparesis never had that test, because it is under-used in ordinary practice — that is a gap in how the condition is normally diagnosed, not a reflection on you or your doctor. We explain the test and what to do about it here.
Who may qualify today
- Brand-name Ozempic, Wegovy, or Rybelsus. Compounded or generic semaglutide, and Mounjaro, Zepbound or Trulicity, don’t fit today’s stomach-injury criteria — tell us anyway; criteria differ by track.
- Gastroparesis confirmed by a gastric emptying study, or gastric obstruction confirmed by other objective testing.
- Diagnosed while taking the medication, or within about 30 days of stopping.
- Diagnosed before December 31, 2024.
- An emergency room visit or hospital admission connected to the injury — one is enough.
- Age 75 or under at intake, and not already represented by another lawyer for this issue.
- Severe nausea and vomiting alone, without one of the diagnoses above, isn’t currently enough for this referral track. Tell us anyway — we would rather give you a straight answer than leave you guessing.
You are not suing your doctor
This is a claim against the companies that made and labeled the medication — Novo Nordisk and Eli Lilly. It is not a claim against the emergency physicians who treated you, your prescriber, or your pharmacy. The clinicians who documented those visits are the people whose records help a claim most.
Free, confidential case review. Marin & Murphy is currently accepting Ozempic (GLP-1) gastroparesis and stomach-injury cases. No fee unless there is a recovery. Marin & Murphy is licensed in Rhode Island, Connecticut, Massachusetts, and South Carolina; matters elsewhere may be referred to lawyers licensed in your state.
Start your free case review or call (888) 348-2735 — answered 24/7. Calling for a family member is fine.
Common questions
Does one ER visit count, or do I need to have been admitted?
One emergency room visit connected to the stomach injury meets the criteria as written — a hospital admission is not separately required. It is also worth mentioning urgent care visits, infusion or hydration appointments, and repeat outpatient visits, because the way a visit was coded in the chart is not always what a patient would assume.
I was that sick but I never went to the hospital. Am I out?
Not automatically, and you should still tell us. The current criteria for this referral track do ask for an emergency room visit or hospital admission, so we will be honest with you about how that affects this particular path. But criteria differ between firms and tracks and change over time, and a review costs you nothing. Based on what is in your records today is a statement about records, which can change — not about you.
Do I need to stop taking the medication to have my case reviewed?
No. Nothing about a case review requires you to stop, and no one here will tell you to. Decisions about continuing or stopping a prescription are between you and your doctor. What you were taking and when simply gets recorded as part of the facts.
How long does this litigation take?
Longer than most people expect. There is no settlement, no verdict, and no trial date in MDL 3094 as of September 2026, and the current gate is a hearing on expert evidence underway September 14–18, 2026. Mass tort litigation of this kind is typically measured in years, not months, and anyone promising you a timeline or a figure is guessing.
Sources
- Case Management Order No. 18, MDL No. 3094, No. 2:24-md-03094 (E.D. Pa. Aug. 23, 2024) (scope includes severe nausea and vomiting)
- Order, MDL No. 3094 (E.D. Pa. Aug. 15, 2025) (Doc. 468) (gastric emptying study requirement)
- Case Management Order No. 32, MDL No. 3094 (Apr. 30, 2026) (Rule 702 hearing, Sept. 14–18, 2026)
- JPML, “Pending MDL Dockets by Actions Pending,” report dated Oct. 1, 2026
- openFDA FAERS adverse event database, semaglutide query, retrieved Aug. 7, 2026
No Ozempic or other GLP-1 lawsuit has been settled, and no court or jury has found that these medications caused anyone’s injury — the litigation is ongoing, with major expert-evidence rulings still ahead. Whether any individual has a claim depends on their own medical records and the law of their state.
Do not stop, start, or change any prescribed medication because of anything on this page. Those decisions belong with your prescriber.
Attorney Advertising.
This page is attorney advertising and is for informational purposes only; it is not legal or medical advice. Prior results do not guarantee a similar outcome. Contacting the firm does not create an attorney-client relationship.
Related stomach-injury topics: bowel obstruction & ileus, feeding tubes, the gastric emptying study, and stomach paralysis (gastroparesis).
More on the Ozempic (GLP-1) litigation
- Ozempic lawsuit overview (hub)
- Ozempic & GLP-1 lawsuit tracker
- Settlement amounts: what’s actually known
- Verdicts & settlements ledger
- The September 2026 expert hearing
- MDL 3163: the vision-loss court
- Stomach paralysis (gastroparesis) claims
- NAION vision-loss claims
- The gastric emptying study, explained
- How compensation works
- Is it too late to file?
- For spouses & caregivers